hair loss   
 
Want Information On...  
| Register Here>> 

Search



Home
Start Researching »
What's New? »
Product Reviews »
Discussion Forum
Photo Gallery
Video Webcasts!
Resource Library
Frequent Questions
Online Chat »
Get your Products »



Hair Loss in Men
Hair Loss in Women
Cosmetic Options
The Alopecia's
Hair Replacement
Surgical Options
Product Center



Sign Up!
  The latest news! The HairlossTalk Monthly Newsletter.

The HairlossTalk Monthly Newsletter is
the source for the
latest information on
treatments, research,
clinical trials in
need of participants, and new technologies.


* ETG Prevents Chemotherapy Hair Loss
Article by HairlossTalk.com
New Research Current Technology Corporation (OTC Bulletin Board: CRTCF) today announced that Dr. Tim Meakin has presented preliminary results in Auckland, New Zealand, from a single center pilot clinical trial to assess the efficacy of the ETG (Electrotrichogenesis) device in the prevention or reduction of hair loss in patients with breast cancer undergoing chemotherapy...

Dr. Meakin reported that thirteen women completed the study. Twelve of the thirteen had the same amount of hair or an increase in the amount of hair at the conclusion of their chemotherapy regimen when compared to baseline. All of the women were diagnosed with breast cancer, treated with CMF chemotherapy over approximately 24 weeks, and received concurrent ETG treatments.

CMF is a combination of the chemotherapy agents Cyclophosphamide, Methotrexate and Fluorouracil (5FU). This combination is a chemotherapy regime frequently prescribed in New Zealand, the United States and many other countries. Alopecia (hair loss) as a result of cancer chemotherapy is a major source of negative changes to self-concept and body image and one of the side effects to chemotherapy people fear most.

Therefore, in addition to assessing hair quantity, quality of life was assessed in this clinical study. All of the women reported that ETG treatments to prevent or reduce chemotherapy induced hair loss, assisted them maintain their sense of well being, and self-esteem.

A full report on the pilot clinical study has been submitted to the medical literature for publication.

Current Technology Corporation is the developer of ETG (Electrotrichogenesis), a patented electrotherapeutic device that provides a clinically proven medical treatment for hair loss, in suitable candidates both male and female. ETG treatments are presently available in several countries around the world.

HLT



© HairlossTalk.com - All Rights Reserved.
Read the Terms under which this service is provided to you.
For Permission to duplicate any content, Email news@hairlosstalk.com
Make sure you're Subscribed to the Newsletter!

· Weekly Chat has Record Attendance! (1217)
· Alt.baldspot Back Online (1216)
· HLT serving over 65k Users Monthly (1081)
· Prevent Hair loss, don't Regrow? (1578)
· Women's Hair Loss Site recognized by AAD (1474)
· Editorial: A Bald-Faced Truth (1492)
· Women's Hair Loss Symposium (1323)
· Editorial: Review of Sci Amer Hair loss Article (1304)
· Lasers for Hair Growth? (3885)
· ETG Prevents Chemotherapy Hair Loss (1284)
· Company Develops New Hair Growth Stimulant (1916)



HairlossTalk Monthly Newsletter


Don't wait for the newsletter! Register to be notified as soon as we publish a new article to the News Center.




In New Research

Why Hair Cloning Doesn't Work just Yet (Part 2)




Privacy Policy | Advertising Policy | Legal Disclaimer | Contact Us | Links

Copyright © 1999-2007 HairlossTalk.com